AIM ImmunoTech Inc. 8K

AIM ImmunoTech regained compliance with NYSE American stockholders’ equity listing standards after completing multiple equity and warrant financing transactions in May–June 2026.

AIM ImmunoTech Inc. announced that the NYSE American has notified the company that it has regained compliance with the exchange’s continued listing standards regarding minimum stockholders’ equity, following a series of equity financings and warrant exercise inducement transactions completed in May and June 2026 that raised approximately $8.5 million in aggregate gross proceeds and increased stockholders’ equity above the $6.0 million requirement; as a result, the below compliance indicator will be removed from its ticker and the company will be taken off the NYSE American’s noncompliant issuer list, though it will remain subject to ongoing listing monitoring.

Filing Facts

CIK

946644

Ticker

-

Form

8K

Source Type

sec

Accession

0001493152-26-028615

Alert Tier

6